Clinical Trial Update: Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cetuximab with capecitabine and cisplatin in advanced esophago-gastric cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• ERBITUX (cetuximab)
• Xeloda (capecitabine)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-05-16